Skip to content
FY'25FY'24FY'23FY'22
$212.69M+1.6%$209.36M+11.9%$187.12M+31.9%$141.84M+50.2%
$42.94M+4.5%$41.09M+16.8%$35.18M+37.8%$25.53M+51.2%
$169.75M+0.9%$168.26M+10.7%$151.94M+30.6%$116.31M+50.0%
79.8%-0.6pp80.4%-0.8pp81.2%-0.8pp82%-0.1pp
$20.28M-1.5%$20.59M+33.3%$15.44M+13.7%$13.58M+33.1%
$140.88M-4.6%$147.64M+4.8%$140.89M+34.7%$104.57M+59.9%
$62.74M+12.6%$55.72M+18.5%$47.03M+42.5%$33M+79.0%
$223.91M0.0%$223.95M+10.1%$203.37M+34.5%$151.15M+60.7%
$223.91M0.0%$223.95M+10.1%$203.37M+34.5%$151.15M+60.7%
-$54.15M+2.8%-$55.69M-8.3%-$51.43M-47.6%-$34.84M-111%
-25.5%+1.1pp-26.6%+0.9pp-27.5%-2.9pp-24.6%-7.1pp
$5.32M+1.2%$5.26M+1.7%$5.17M+17.5%$4.4M+8.3%
$2.78M-43.1%$4.88M-27.5%$6.73M+412%$1.31M+8,653%
-$4.85M-8,715%-$55K-103%$1.9M+124%-$7.97M-97.2%
-$59M-5.8%-$55.74M-12.6%-$49.53M-15.7%-$42.82M-108%
-27.7%-1.1pp-26.6%-0.2pp-26.5%+3.7pp-30.2%-8.4pp
-$0.93-3.3%-$0.90-11.1%-$0.81-6.6%-$0.76-81.0%
-$0.93-3.3%-$0.90-11.1%-$0.81-6.6%-$0.76-76.7%
252.5M+1.7%248.2M+2.3%242.5M+9.8%220.8M+17.3%
252.5M+1.7%248.2M+2.3%242.5M+9.8%220.8M
-$59.03M-5.8%-$55.81M-13.1%-$49.34M-15.2%-$42.84M-106%
$2.78M-43.1%$4.88M-27.5%$6.73M+412%$1.31M+8,653%
-$4.85M-8,715%-$55K-103%$1.9M+124%-$7.97M-97.2%
$432K+33.3%$324K-5.3%$342K+185%-$403K-40,400%
-$54.15M+2.8%-$55.69M-8.3%-$51.43M-47.6%-$34.84M-111%
-$43.53M+7.9%-$47.27M-2.6%-$46.07M-40.5%-$32.79M-107%
-$43.53M+7.9%-$47.27M-2.6%-$46.07M-40.5%-$32.79M-107%
-20.5%+2.1pp-22.6%+2.0pp-24.6%-1.5pp-23.1%-6.4pp
-$54.15M+2.8%-$55.69M-8.3%-$51.43M-47.6%-$34.84M-111%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What is Treace Medical Concepts, Inc.'s revenue?
Treace Medical Concepts, Inc. (TMCI) generated $207.3M in revenue over the trailing twelve months, down 1.7% year over year.
Is Treace Medical Concepts, Inc. profitable?
Treace Medical Concepts, Inc. is not currently profitable: it reported a net loss of $61.0M over the trailing twelve months, a -29.4% net margin.
What are Treace Medical Concepts, Inc.'s profit margins?
Gross margin is 79.7% and operating margin is -26.9%, with a -29.4% net margin.
What is Treace Medical Concepts, Inc.'s earnings per share?
Treace Medical Concepts, Inc.'s diluted EPS over the trailing twelve months is $-0.96.
Where does Treace Medical Concepts, Inc.'s income statement data come from?
Every line is extracted from Treace Medical Concepts, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.